Data-driven Bayesian network learning analysis on the regulatory mechanism between carcinogenic genes and immune cells

Weixiao Bu, Huaxia Mu, Mengyao Gao, Weiqiang Su, Fuyan Shi, Qinghua Wang, Suzhen Wang, Yujia Kong
{"title":"Data-driven Bayesian network learning analysis on the regulatory mechanism between carcinogenic genes and immune cells","authors":"Weixiao Bu,&nbsp;Huaxia Mu,&nbsp;Mengyao Gao,&nbsp;Weiqiang Su,&nbsp;Fuyan Shi,&nbsp;Qinghua Wang,&nbsp;Suzhen Wang,&nbsp;Yujia Kong","doi":"10.1002/ctd2.257","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>In recent years, it has become a research focus to accurately extract key genes influencing the occurrence and development of diseases from massive genomic data and study their regulatory mechanisms. Further exploration of these large databases is beneficial for us to identify key regulatory mechanisms in the occurrence and development of diseases, providing direction and theoretical basis for subsequent experimental design and research.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>By using data from The Cancer Genome Atlas (TCGA) for lung adenocarcinoma (LUAD), the immune cell content of patients was obtained through deconvolution calculations in CIBERSORTx. Combined with Bayesian network inference methods, the impact of key gene expression on the heterocellular network influencing lung cancer was analyzed.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We found CD36 and ADRA1A genes were identified as two key mRNA genes influencing lung adenocarcinoma. The sensitivity analysis shows that the model performs well on both the testing set (error rate = 4%, AUC = 0.9804), the training set (error rate = 5.637%, AUC = 0.9746) and the verification set (error rate = 28.85%, AUC = 0.8689). The model has excellent predictive capabilities.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>We found that CD36 and ADRA1A genes may influence the development of lung cancer by affecting regulatory T cell and follicular helper T cell populations. Additionally, plasma cells may affect the expression of the CD36 gene. And the mutual information calculated by the model for these two genes is also the highest, indicating their potential as tumour biomarkers. Combining the network model, it can be inferred that CD36 and ADRA1A are likely to influence the occurrence and development of the disease through follicular helper T cells and regulatory T cells.</p>\n </section>\n </div>","PeriodicalId":72605,"journal":{"name":"Clinical and translational discovery","volume":"3 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctd2.257","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and translational discovery","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctd2.257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In recent years, it has become a research focus to accurately extract key genes influencing the occurrence and development of diseases from massive genomic data and study their regulatory mechanisms. Further exploration of these large databases is beneficial for us to identify key regulatory mechanisms in the occurrence and development of diseases, providing direction and theoretical basis for subsequent experimental design and research.

Methods

By using data from The Cancer Genome Atlas (TCGA) for lung adenocarcinoma (LUAD), the immune cell content of patients was obtained through deconvolution calculations in CIBERSORTx. Combined with Bayesian network inference methods, the impact of key gene expression on the heterocellular network influencing lung cancer was analyzed.

Results

We found CD36 and ADRA1A genes were identified as two key mRNA genes influencing lung adenocarcinoma. The sensitivity analysis shows that the model performs well on both the testing set (error rate = 4%, AUC = 0.9804), the training set (error rate = 5.637%, AUC = 0.9746) and the verification set (error rate = 28.85%, AUC = 0.8689). The model has excellent predictive capabilities.

Conclusion

We found that CD36 and ADRA1A genes may influence the development of lung cancer by affecting regulatory T cell and follicular helper T cell populations. Additionally, plasma cells may affect the expression of the CD36 gene. And the mutual information calculated by the model for these two genes is also the highest, indicating their potential as tumour biomarkers. Combining the network model, it can be inferred that CD36 and ADRA1A are likely to influence the occurrence and development of the disease through follicular helper T cells and regulatory T cells.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
致癌基因与免疫细胞调控机制的数据驱动贝叶斯网络学习分析
背景 近年来,从海量基因组数据中准确提取影响疾病发生和发展的关键基因并研究其调控机制已成为研究的重点。对这些大型数据库的进一步探索,有利于我们发现疾病发生和发展过程中的关键调控机制,为后续的实验设计和研究提供方向和理论依据。 方法 利用癌症基因组图谱(TCGA)中的肺腺癌(LUAD)数据,通过CIBERSORTx中的去卷积计算获得患者的免疫细胞含量。结合贝叶斯网络推断方法,分析了关键基因表达对影响肺癌的异细胞网络的影响。 结果 我们发现 CD36 和 ADRA1A 基因是影响肺腺癌的两个关键 mRNA 基因。灵敏度分析表明,该模型在测试集(误差率 = 4%,AUC = 0.9804)、训练集(误差率 = 5.637%,AUC = 0.9746)和验证集(误差率 = 28.85%,AUC = 0.8689)上均表现良好。该模型具有出色的预测能力。 结论 我们发现 CD36 和 ADRA1A 基因可能会影响调节性 T 细胞和滤泡辅助性 T 细胞群,从而影响肺癌的发生。此外,浆细胞也可能影响 CD36 基因的表达。模型计算出的这两个基因的互信息也是最高的,表明它们有可能成为肿瘤生物标记物。结合网络模型,可以推断 CD36 和 ADRA1A 可能通过滤泡辅助性 T 细胞和调节性 T 细胞影响疾病的发生和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
0
期刊最新文献
Application of machine learning-based phenotyping in individualized fluid management in critically ill patients with heart failure An auxiliary diagnostic approach based on traditional Chinese medicine constitutions for older patients with frailty Use of short-term cervical collars is associated with emotional discomfort Challenges and advances of immune checkpoint therapy Drug repurposing: Bortezomib in the treatment of PTEN-deficient iCCA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1